Literature DB >> 29366766

Breast cancer amelioration by Butea monosperma in-vitro and in-vivo.

Prachi Karia1, Kirti V Patel2, Shri S P Rathod3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Butea monosperma belonging to family Fabaceae is used in the Indian traditional medicine (Ayurveda) for various ailments including abdominal tumors and possess anti-estrogenic activity. AIM OF THE STUDY: The present study is aimed at investigating the chemo-preventive potential of Butea monosperma in breast cancer and elucidating it's mechanism of action by assessing its effect on key processes like apoptosis, angiogenesis and metastasis.
METHODS: Cytotoxic potential of methanol extract of Butea monosperma flower (MEBM) was tested in MCF-7 (estrogen receptor positive), MDA-MB-231 (triple negative) and MDA-MB-453 (HER2 positive) human breast cancer cells by MTT assay. Chemo-preventive potential was evaluated in-vivo in Methylnitrosourea (MNU) induced mammary cancer in nulliparous Sprague-Dawley rats. The mechanism for anticancer potential was screened by in-vitro studies involving Annexin V- FITC assay (apoptosis), Chick Chorioallantoic Membrane assay (angiogenesis) and Migration assay (metastasis). Statistical analysis was done by one way and two way ANOVA (for Growth Rate and feed consumption efficiency) followed by post hoc Bonferroni's test with P value < 0.05.
RESULTS: It is observed that the exposure of MEBM, at various concentrations and time intervals to different cell lines, resulted in decreased cell proliferation. The IC50 value of MCF-7 cells was found significantly less than that of MDA-MB-231 and MDA-MB-453 cells, which indicated that the extract of said medicinal plant were more potent inhibitors of estrogen positive breast cancer cells than other types of breast cancer cells in vitro. Corroborative evidences were acquired in MNU actuated mammary carcinogenesis where MEBM constricted tumor parameters, decreased expression of estrogen and progesterone, nucleic acid content and increased latency period. MEBM also induced apoptosis, inhibited angiogenesis and metastasis in-vitro.
CONCLUSION: Selective cytotoxic activity in MCF-7 estrogen positive breast cancer cells and inhibition of growth of mammary carcinoma in-vivo by methanol extract of Butea monosperma flowers (MEBM) suggests chemo-prevention through modulation of estrogen and progesterone receptor, apoptotic, anti-angiogenesis and anti-metastatic activity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Butea monosperma; Cell line; MNU

Mesh:

Substances:

Year:  2018        PMID: 29366766     DOI: 10.1016/j.jep.2017.12.026

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  The 3D in vivo chorioallantoic membrane model and its role in breast cancer research.

Authors:  Cynthia Kohl; Thiha Aung; Silke Haerteis; Atanas Ignatov; Olaf Ortmann; Thomas Papathemelis
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-05       Impact factor: 4.322

2.  Efficacy of Quercetin-Sensitized Cisplatin against N-Nitroso-NMethylurea Induced Testicular Carcinogenesis in Wistar Rats.

Authors:  Hend Hgm El-Diasty; Hassan El-Sayyad; Sherif Refaat; Heba A El-Ghaweet
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

3.  Brevilin A Inhibits STAT3 Signaling and Induces ROS-Dependent Apoptosis, Mitochondrial Stress and Endoplasmic Reticulum Stress in MCF-7 Breast Cancer Cells.

Authors:  Muhammad Zubair Saleem; Muhammad Azhar Nisar; Mohammed Alshwmi; Syed Riaz Ud Din; Yaser Gamallat; Muhammad Khan; Tonghui Ma
Journal:  Onco Targets Ther       Date:  2020-01-15       Impact factor: 4.147

4.  The complete chloroplast genome sequence of Butea monosperma (Fabaceae).

Authors:  Dan Wei; Xiaogang Ding; Hangyong Zhu; Zhongrui Zhang; Haiyan Yang; Renchao Zhou; Seping Dai; Geng Zhang
Journal:  Mitochondrial DNA B Resour       Date:  2020-08-28       Impact factor: 0.658

Review 5.  A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.

Authors:  Hailemeleak Regassa; Anuradha Sourirajan; Vikas Kumar; Sadanand Pandey; Deepak Kumar; Kamal Dev
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

6.  Health-related quality of life in breast cancer patients in Asia: A meta-analysis and systematic review.

Authors:  Xinyu Chen; Chenxi Wu; Dingxi Bai; Jing Gao; Chaoming Hou; Tingting Chen; Lulu Zhang; Huan Luo
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.